Table 5 Comparison of baseline parameters between subjects achieving or not achieving remission NAFLD (n = 134).

From: Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up

 

Sustained (n = 101)

Remission (n = 33)

P value

Age (yr)

47.0 (39.0,55.0)

49 (44.5,54.0)

0.446

Gender (% male)

37 (36.6%)

24 (72.4%)

<0.001*

BMI (kg/m2)

27.7 (25.9,29.7)

25.9 (24.8,28.5)

0.004*

WC (cm)

91.0 (85.0,97.0)

87.0 (82.0,94.5)

0.158

SBP (mmHg)

135 (120,150)

130 (120,140)

0.352

DBP (mmHg)

90 (80,100)

80 (80,90)

0.068

GGT (U/L)

29.9 (19.1,50.5)

35.3 (24.3,62.3)

0.383

ALT (U/L)

27.6 (16.7,41.7)

23.1 (15.4,35.6)

0.278

AST (U/L)

23.8 (19.0,30.1)

24.5 (18.2,29.8)

0.696

TC (mmol/l)

4.80 (4.19,5.50)

4.78 (4.10,5.46)

0.979

LDL-C (mmol/l)

3.40 (2.87,3.90)

3.40 (2.75,3.70)

0.716

HDL-C (mmol/l)

1.30 (1.10,1.50)

1.40 (1.10.1.50)

0.6

TG (mmol/l)

1.78 (1.29,2.63)

2.14 (1.35,2.90)

0.542

FBG (mmol/l)

5.08 (4.62,5.50)

5.04 (4.51,5.57)

0.524

Diabetes, n (%)

14 (13.9%)

2 (6.1%)

0.476

Hypertension, n (%)

55 (54.5%)

15 (45.5%)

0.423

Obesity, n (%)

46 (45.5%)

10 (30.3%)

0.031*

Overweight, n (%)

47 (46.5%)

15 (45.5%)

Dyslipidaemia, n (%)

83 (82.2%)

26 (78.8%)

0.797

Hyper-TC, n (%)

35 (34.7%)

10 (30.3%)

0.678

Hyper-LDL-C, n (%)

54 (53.5%)

17 (51.5%)

1

Hyper-TG, n (%)

54 (53.5%)

21 (63.6%)

0.322

Hypo-HDL-C, n (%)

16 (15.8%)

5 (15.2%)

1

  1. The results are expressed as medians (25th quartile, 75th quartile) or frequencies (percentage).
  2. NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
  3. *Indicates statistical significance.
Back to article page